{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T10:23:27Z","timestamp":1789899807402,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,17]],"date-time":"2016-06-17T00:00:00Z","timestamp":1466121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labor and Welfare, Japan","doi-asserted-by":"publisher","award":["26460816"],"award-info":[{"award-number":["26460816"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Center for Research on Influenza Pathogenesis","award":["CRIP, HHSN266200700010C"],"award-info":[{"award-number":["CRIP, HHSN266200700010C"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.antiviral.2016.06.007","type":"journal-article","created":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T05:14:18Z","timestamp":1466572458000},"page":"170-177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["Antiviral susceptibility of influenza viruses isolated from patients pre- and post-administration of favipiravir"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9064-4699","authenticated-orcid":false,"given":"Emi","family":"Takashita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Ejima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichiro","family":"Fujisaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousuke","family":"Furuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kawaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takato","family":"Odagiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.antiviral.2016.06.007_bib1","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1128\/JVI.02346-12","article-title":"T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in\u00a0vitro","volume":"87","author":"Baranovich","year":"2013","journal-title":"J.\u00a0Virol."},{"issue":"7","key":"10.1016\/j.antiviral.2016.06.007_bib2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3727\/095535491820873191","article-title":"Use of an aqueous soluble tetrazolium\/formazan assay for cell growth assays in culture","volume":"3","author":"Cory","year":"1991","journal-title":"Cancer Commun."},{"issue":"3","key":"10.1016\/j.antiviral.2016.06.007_bib3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1254\/jphs.14156SC","article-title":"Characterization of susceptibility variants of influenza virus grown in the presence of T-705","volume":"126","author":"Daikoku","year":"2014","journal-title":"J.\u00a0Pharmacol. Sci."},{"issue":"10","key":"10.1016\/j.antiviral.2016.06.007_bib4","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1093\/jac\/dku209","article-title":"Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral","volume":"69","author":"Delang","year":"2014","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2016.06.007_bib5","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1128\/JVI.01783-09","article-title":"Molecular determinants of adaptation of highly pathogenic avian influenza H7N7 viruses to efficient replication in the human host","volume":"84","author":"de Wit","year":"2010","journal-title":"J.\u00a0Virol."},{"issue":"4","key":"10.1016\/j.antiviral.2016.06.007_bib6","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/AAC.46.4.977-981.2002","article-title":"In\u00a0vitro and in\u00a0vivo activities of anti-influenza virus compound T-705","volume":"46","author":"Furuta","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.antiviral.2016.06.007_bib7","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/AAC.49.3.981-986.2005","article-title":"Mechanism of action of T-705 against influenza virus","volume":"49","author":"Furuta","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.antiviral.2016.06.007_bib8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.antiviral.2009.02.198","article-title":"T-705 (favipiravir) and related compounds: novel broad-spectrum inhibitors of RNA viral infections","volume":"82","author":"Furuta","year":"2009","journal-title":"Antivir. Res."},{"issue":"2","key":"10.1016\/j.antiviral.2016.06.007_bib9","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","article-title":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor","volume":"100","author":"Furuta","year":"2013","journal-title":"Antivir. Res."},{"issue":"7208","key":"10.1016\/j.antiviral.2016.06.007_bib10","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/nature07120","article-title":"Crystal structure of the polymerase PA(C)-PB1(N) complex from an avian influenza H5N1 virus","volume":"454","author":"He","year":"2008","journal-title":"Nature"},{"issue":"96","key":"10.1016\/j.antiviral.2016.06.007_bib11","article-title":"Characteristics of oseltamivir-resistant influenza A (H1N1) pdm09 virus during the 2013-2014 influenza season in Mainland China","volume":"12","author":"Huang","year":"2015","journal-title":"Virol. J."},{"issue":"7","key":"10.1016\/j.antiviral.2016.06.007_bib12","doi-asserted-by":"crossref","first-page":"e68347","DOI":"10.1371\/journal.pone.0068347","article-title":"The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5\u2019-triphosphate towards influenza A virus polymerase","volume":"8","author":"Jin","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.antiviral.2016.06.007_bib13","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1073\/pnas.0909603107","article-title":"T-705 (favipiravir) activity against lethal H5N1 influenza A viruses","volume":"107","author":"Kiso","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6223","key":"10.1016\/j.antiviral.2016.06.007_bib14","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1126\/science.347.6223.701","article-title":"Infectious diseases. Ebola drug trials lurch ahead","volume":"347","author":"Kupferschmidt","year":"2015","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.antiviral.2016.06.007_bib15","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1128\/AAC.01339-05","article-title":"Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use","volume":"50","author":"Monto","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7208","key":"10.1016\/j.antiviral.2016.06.007_bib16","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/nature07225","article-title":"The structural basis for an essential subunit interaction in influenza virus RNA polymerase","volume":"454","author":"Obayashi","year":"2008","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.antiviral.2016.06.007_bib17","doi-asserted-by":"crossref","first-page":"10918","DOI":"10.1128\/JVI.01140-10","article-title":"High level of genetic compatibility between swine-origin H1N1 and highly pathogenic avian H5N1 influenza viruses","volume":"84","author":"Octaviani","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.06.007_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.antiviral.2014.02.014","article-title":"Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model","volume":"105","author":"Oestereich","year":"2014","journal-title":"Antivir. Res."},{"issue":"1","key":"10.1016\/j.antiviral.2016.06.007_bib19","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3201\/eid2101.141006","article-title":"Oseltamivir-resistant influenza A(H1N1)pdm09 viruses, United States, 2013\u201314","volume":"21","author":"Okomo-Adhiambo","year":"2015","journal-title":"Emerg. Infect. Dis."},{"issue":"8","key":"10.1016\/j.antiviral.2016.06.007_bib20","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1128\/AAC.02546-13","article-title":"The enterovirus protease inhibitor rupintrivir exerts cross-genotypic anti-norovirus activity and clears cells from the norovirus replicon","volume":"58","author":"Rocha-Pereira","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.antiviral.2016.06.007_bib21","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1128\/AAC.00649-13","article-title":"Mechanism of action of T-705 ribosyl triphosphate against influenza virus RNA polymerase","volume":"57","author":"Sangawa","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.antiviral.2016.06.007_bib22","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1128\/AAC.01051-06","article-title":"Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice","volume":"51","author":"Sidwell","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.antiviral.2016.06.007_bib23","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1128\/AAC.01739-09","article-title":"In\u00a0vitro antiviral activity of favipiravir (t-705) against drug-resistant influenza and 2009 A(H1N1) viruses","volume":"54","author":"Sleeman","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.antiviral.2016.06.007_bib24","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1128\/AAC.45.3.743-748.2001","article-title":"Cyclopentane neuraminidase inhibitors with potent in\u00a0vitro anti-influenza virus activities","volume":"45","author":"Smee","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.06.007_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.antiviral.2014.01.012","article-title":"Post-exposure efficacy of oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model","volume":"104","author":"Smither","year":"2014","journal-title":"Antivir. Res."},{"issue":"6","key":"10.1016\/j.antiviral.2016.06.007_bib26","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1750-2659.2011.00331.x","article-title":"Influenza research database: an integrated bioinformatics resource for influenza research and surveillance","volume":"6","author":"Squires","year":"2012","journal-title":"Influ. Other Respir. Viruses"},{"issue":"6","key":"10.1016\/j.antiviral.2016.06.007_bib27","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/irv.12132","article-title":"Characterization of neuraminidase inhibitor-resistant influenza A(H1N1)pdm09 viruses isolated in four seasons during pandemic and post-pandemic periods in Japan","volume":"7","author":"Takashita","year":"2013","journal-title":"Influ. Other Respir. Viruses"},{"issue":"1","key":"10.1016\/j.antiviral.2016.06.007_bib28","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.1.20666","article-title":"A\u00a0community cluster of influenza A(H1N1)pdm09 virus exhibiting cross-resistance to oseltamivir and peramivir in Japan, November to December 2013","volume":"19","author":"Takashita","year":"2014","journal-title":"Euro Surveill."},{"issue":"5","key":"10.1016\/j.antiviral.2016.06.007_bib29","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1128\/AAC.04836-14","article-title":"Characterization of a large cluster of influenza A(H1N1)pdm09 virus cross-resistant to oseltamivir and peramivir during the 2013\/2014 influenza season in Japan","volume":"59","author":"Takashita","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.06.007_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.antiviral.2015.02.003","article-title":"Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013\u20132014","volume":"117","author":"Takashita","year":"2015","journal-title":"Antivir. Res."},{"issue":"6","key":"10.1016\/j.antiviral.2016.06.007_bib31","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3851\/IMP1194","article-title":"Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996\u20132007","volume":"14","author":"Tashiro","year":"2009","journal-title":"Antivir. Ther."},{"issue":"6","key":"10.1016\/j.antiviral.2016.06.007_bib32","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3201\/eid1606.091623","article-title":"Oseltamivir-resistant influenza viruses A(H1N1) during 2007-2009 influenza seasons","volume":"16","author":"Ujike","year":"2010","journal-title":"Jpn. Emerg. Infect. Dis."},{"issue":"3","key":"10.1016\/j.antiviral.2016.06.007_bib33","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3201\/eid1703.101188","article-title":"Monitoring and characterization of oseltamivir resistant pandemic (H1N1) 2009 virus, Japan, 2009\u20132010","volume":"17","author":"Ujike","year":"2011","journal-title":"Emerg. Infect. Dis."},{"issue":"7468","key":"10.1016\/j.antiviral.2016.06.007_bib34","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nature12392","article-title":"Characterization of H7N9 influenza A viruses isolated from humans","volume":"501","author":"Watanabe","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.06.007_bib35","series-title":"Laboratory Methodologies for Testing the Antiviral Susceptibility of Influenza Viruses: Reference Viruses for Validation and Controls","author":"World Health Organization","year":"2012"},{"issue":"39","key":"10.1016\/j.antiviral.2016.06.007_bib36","first-page":"369","article-title":"Meetings of the WHO working group on surveillance of influenza antiviral susceptibility-Geneva, November 2011 and June 2012","volume":"87","author":"World Health Organization","year":"2012","journal-title":"Wkly. Epidemiol. Rec."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216303382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216303382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T21:17:41Z","timestamp":1568063861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216303382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":36,"alternative-id":["S0166354216303382"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.06.007","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral susceptibility of influenza viruses isolated from patients pre- and post-administration of favipiravir","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}